Vaccine Supply and Innovation

Division of Health Promotion and Disease Prevention, National Research Council

• 1 Front Matter; 2 1 Summary; 3 2 Vaccines: Past, Present, and Future; 4 3 Vaccine Availability: Concerns, Barriers, and Impediments; 5 4 Economic Aspects of Vaccine Innovation and Manufacturing; 6 5 Vaccine Injury; 7 6 Liability for the Production and Sale of Vaccines; 8 7 An Approach to Problems of Communication, Coordination, and Collaboration in Vaccine Policy; 9 8 Vaccine Injury Compensation and Liability Remedies; 10 Appendix A: Product License Holders; 11 Appendix B: A Vaccine Supply Public Insurance Option; 12 Appendix C: No-Fault Vaccine Injury Insurance; 13 Appendix D: Injury Compensation Systems in the United States; 14 Appendix E: Vaccine-Injury Compensation in Other Countries; 15 Appendix F: Proposed Vaccine-Injury Compensation Systems; 16 Appendix G: Mechanisms Used in Other Countries to Ensure Vaccine Supply; 17 Appendix H: Background Papers; 18 Appendix I: Biographical Notes on Committee Members and Consultants; 19 Appendix J: Recommendations for the Proposed Vaccine Commission; 20 Index